Filtered By:
Condition: Low Testosterone
This page shows you your search results in order of relevance. This is page number 5.
Order by Relevance | Date
Total 106 results found since Jan 2013.
Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failure
Rev Endocr Metab Disord. 2021 Feb 22. doi: 10.1007/s11154-021-09628-2. Online ahead of print.ABSTRACTThe cardiovascular (CV) benefit and safety of treating low testosterone conditions is a matter of debate. Although testosterone deficiency has been linked to a rise in major adverse CV events, most of the studies on testosterone replacement therapy were not designed to assess CV risk and thus excluded men with advanced heart failure or recent history of myocardial infarction or stroke. Besides considering observational, interventional and prospective studies, this review article evaluates the impact of testosterone on ather...
Source: ENDOCR REV - February 22, 2021 Category: Endocrinology Authors: Baris Gencer Marco Bonomi Maria Pia Adorni Cesare R Sirtori Fran çois Mach Massimiliano Ruscica Source Type: research
Endocrine manifestations and new developments in mitochondrial disease
Endocr Rev. 2021 Oct 13:bnab036. doi: 10.1210/endrev/bnab036. Online ahead of print.ABSTRACTMitochondrial diseases are a group of common inherited diseases causing disruption of oxidative phosphorylation. Some patients with mitochondrial disease have endocrine manifestations, with diabetes being predominant but also include hypogonadism, hypoadrenalism and hypoparathyroidism. There have been major developments in mitochondrial disease over the last decade that have major implications for all patients. The collection of large cohorts of patients has better defined the phenotype of mitochondrial diseases and the majority of ...
Source: Endocrine Reviews - October 13, 2021 Category: Endocrinology Authors: Yi Shiau Ng Albert Zishen Lim Grigorios Panagiotou Doug M Turnbull Mark Walker Source Type: research
